Business & Regulation

Pharma depends on academia, but that relationship can become better… and more fluid

More than a few pearls of wisdom were dropped at this key gathering in London, and we were there to catch them.

For any organization, one ill-timed tweet can create enormous backlash.

In the face of economic uncertainty in a post-pandemic world, how will the cell and gene field respond?

Sitting Down With… Gen Li, CEO, Phesi

A year of turmoil, and a year of change – just how healthy are pharma and the life sciences?

After years of progress in the courts, could one verdict in California give unproven stem cell clinics an unwelcome boost?

Can AI realistically transform data management in pharma? Yes. And it’s already begun.

What did switching from client to constructor teach a seasoned biotech professional?

Fake tweet announcing free insulin leads to mayhem.